These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 25640063)

  • 1. The potential of CD44 as a diagnostic and prognostic tool in oral cancer.
    Emich H; Chapireau D; Hutchison I; Mackenzie I
    J Oral Pathol Med; 2015 Jul; 44(6):393-400. PubMed ID: 25640063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of cell adhesion genes in cancer stem-like cells isolated from primary oral squamous cell carcinomas.
    Mishra A; Sriram H; Chandarana P; Tanavde V; Kumar RV; Gopinath A; Govindarajan R; Ramaswamy S; Sadasivam S
    Tumour Biol; 2018 May; 40(5):1010428318780859. PubMed ID: 29888653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
    Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
    J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
    Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
    Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.
    Biddle A; Gammon L; Fazil B; Mackenzie IC
    PLoS One; 2013; 8(2):e57314. PubMed ID: 23437366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
    Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
    J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Stratification System for Oral Cancer Screening.
    Pereira LH; Reis IM; Reategui EP; Gordon C; Saint-Victor S; Duncan R; Gomez C; Bayers S; Fisher P; Perez A; Goodwin WJ; Hu JJ; Franzmann EJ
    Cancer Prev Res (Phila); 2016 Jun; 9(6):445-55. PubMed ID: 27020654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44: a cancer stem cell-related biomarker with predictive potential for radiotherapy.
    Baumann M; Krause M
    Clin Cancer Res; 2010 Nov; 16(21):5091-3. PubMed ID: 20861165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression.
    Wang SJ; Earle C; Wong G; Bourguignon LY
    Head Neck; 2013 Apr; 35(4):511-20. PubMed ID: 22473523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
    Patil S
    Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in CD44s expression in HNSCC tumours of different areas within the oral cavity.
    Krump M; Ehrmann J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Dec; 157(4):280-3. PubMed ID: 23235720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 as a stem cell marker in head and neck squamous cell carcinoma.
    Faber A; Barth C; Hörmann K; Kassner S; Schultz JD; Sommer U; Stern-Straeter J; Thorn C; Goessler UR
    Oncol Rep; 2011 Aug; 26(2):321-6. PubMed ID: 21617876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
    J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
    Niranjan KC; Raj M; Hallikeri K
    Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
    Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
    Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells.
    Furusawa J; Zhang H; Vural E; Stone A; Fukuda S; Oridate N; Fang H; Ye Y; Suen JY; Fan CY
    Otolaryngol Head Neck Surg; 2011 Jun; 144(6):900-9. PubMed ID: 21493336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on challenges and opportunities in characterizing oral cancer stem cells.
    Sadasivam S; Subramanian R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1011-1021. PubMed ID: 32114422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
    Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
    Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.